Novel therapies target myasthenia gravis

JAMA. 2007 Jul 11;298(2):163-4. doi: 10.1001/jama.298.2.163.
No abstract available

Publication types

  • News

MeSH terms

  • Animals
  • Cholinesterase Inhibitors / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Myasthenia Gravis / drug therapy*
  • Oligodeoxyribonucleotides
  • Oligonucleotides, Antisense / therapeutic use

Substances

  • Cholinesterase Inhibitors
  • EN101
  • Immunosuppressive Agents
  • Oligodeoxyribonucleotides
  • Oligonucleotides, Antisense
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Cyclophosphamide